Provenance du réseau au premier degré de Silinda Neou
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 23 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Silinda Neou via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| C.R. BARD | Medical Specialties | General Counsel | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director of Finance/CFO Comptroller/Controller/Auditor | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania. | College/University | Undergraduate Degree | |
| LEXICON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| CURIS, INC. | Biotechnology | Director/Board Member | |
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| AMYRIS, INC. | Chemicals: Specialty | Corporate Officer/Principal | |
| ATRECA, INC. | Biotechnology | Director/Board Member | |
| University of Pittsburgh | College/University | Corporate Officer/Principal | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Doctorate Degree | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
| Gustavus Adolphus College | College/University | Undergraduate Degree | |
| Hastings College | College/University | Graduate Degree | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree | |
| University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of Colorado | College/University | Undergraduate Degree | |
| The University of California, San Francisco | College/University | Doctorate Degree | |
| University of Tennessee | College/University | Doctorate Degree | |
| Baylor College of Medicine | College/University | Doctorate Degree Corporate Officer/Principal | |
Ysios Capital Partners SGEIC SA
 Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona. | Investment Managers | Private Equity Investor | |
| PROTAGONIST THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Weill Cornell Medical College | College/University | Doctorate Degree | |
| ARGENX SE | Pharmaceuticals: Other | Director/Board Member | |
Jewish Hospital
 Jewish Hospital Hospital/Nursing ManagementHealth Services Part of Community Health Systems, Inc., Jewish Hospital is a hospital. The company is based in Cincinnati, OH. Jewish Hospital was acquired by Mercy Health Partners, Inc. (Pennsylvania), a NPO of Community Health Systems, Inc. from Jewish Foundation of Cincinnati on March 01, 2010 for $180 million. | Hospital/Nursing Management | Corporate Officer/Principal | |
| IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| DERMIRA, INC. | Pharmaceuticals: Major | General Counsel | |
| University of California | College/University | Corporate Officer/Principal | |
Inbiomotion SL
 Inbiomotion SL Medical SpecialtiesHealth Technology Inbiomotion SL designs and develops diagnostic assays. It focus on genetic biomarkers, which predict the bone-specific metastases in cancer patients. The firm develops biomarker in breast cancer primary tumors for predicting the bone relapse. The company was founded by in 2010 and is headquartered in Barcelona, Spain. | Medical Specialties | Director/Board Member | |
Amphivena Therapeutics, Inc.
 Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA. | Drugstore Chains | Director/Board Member | |
| Stanford University School of Medicine | College/University | Doctorate Degree | |
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Biotechnology | Director/Board Member | |
| The University of Colorado School of Medicine | College/University | Doctorate Degree | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| UNITY BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member | |
| HARPOON THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
BIOMILQ, Inc.
 BIOMILQ, Inc. Miscellaneous Commercial ServicesCommercial Services BIOMILQ operates mother-cultured infant breast milk company. The company was founded by Leila Strickland and Michelle Egger and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Chairman | |
| ARCUS BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Maverick Therapeutics, Inc.
 Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | Biotechnology | Director/Board Member | |
K36 Therapeutics, Inc.
 K36 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology K36 Therapeutics, Inc. develops small molecule therapeutics. The company is based in Cambridge, MA. The company was founded in 2021. The CEO is Terry Connolly. | Pharmaceuticals: Major | Director/Board Member | |
| ENLIVEN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| ZAI LAB LIMITED | Biotechnology | Chief Tech/Sci/R&D Officer |
Statistiques
Internationale
| Etats-Unis | 46 |
| Espagne | 3 |
| Pays-Bas | 2 |
| Chine | 2 |
Sectorielle
| Health Technology | 27 |
| Consumer Services | 17 |
| Commercial Services | 3 |
| Finance | 3 |
| Process Industries | 2 |
Opérationnelle
| Director/Board Member | 52 |
| Corporate Officer/Principal | 41 |
| Independent Dir/Board Member | 26 |
| Undergraduate Degree | 17 |
| Chief Tech/Sci/R&D Officer | 16 |
Relations les plus connectées
| Insiders | |
|---|---|
| Lori Kunkel | 27 |
| Julia Gregory | 22 |
| Judith Reinsdorf | 18 |
| David Lacey | 12 |
| Jason Daniel Kantor | 11 |
| Eric C. Schlezinger | 10 |
| Christine Ring | 10 |
| Stefani Wolff | 8 |
| Edward Saltzman | 7 |
| Michael Mischke-Reeds | 6 |
| Hans van Houte | 6 |
| Michael T. Lotze | 6 |
| Arthur Sands | 6 |
| Paul Silva | 5 |
| Gwenn Hansen | 4 |
- Bourse
- Insiders
- Silinda Neou
- Connexions Sociétés